Affirm Prone Biopsy System
Device Breast and Skeletal Health
PDI 15420045504721
General payments
$148,572
Research payments
$63,560
Through program year 2025, $148,572 in general payments and $63,560 in research payments were reported against Affirm Prone Biopsy System (Breast and Skeletal Health).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $77,774 | 123 |
| 2024 | General | $20,804 | 163 |
| 2023 | General | $43,380 | 652 |
| 2023 | Research | $9,660 | 1 |
| 2022 | General | $4,316 | 129 |
| 2022 | Research | $53,900 | 4 |
| 2021 | General | $2,297 | 112 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,179 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.